Tareq Abadl: Detecting the Hidden Risk of NAIT in the Lab
Tareq Abadl, Medical Laboratory Specialist and Director of the Blood Bank at Dr. Abdelkader Al-Mutawakkil Hospital, shared a post on LinkedIn:
“NAIT (Neonatal Alloimmune Thrombocytopenia): When the Lab Detects the Hidden Risk.
Neonatal Alloimmune Thrombocytopenia (NAIT) is a condition where the fetus or newborn develops severe thrombocytopenia due to maternal anti-platelet alloantibodies.
The most common antibody involved is anti-HPA-1a.
Although rare, NAIT can lead to severe neonatal thrombocytopenia and intracranial hemorrhage, making early laboratory recognition critical.
In many cases, the laboratory alert is what changes the delivery and transfusion plan.
Top red flags the lab should recognize
- History of a previously affected infant: A mother with a prior baby who had unexplained thrombocytopenia or neonatal bleeding should raise suspicion for NAIT.
- Severe thrombocytopenia at birth: Platelet count less than 50 × 10⁹/L in a newborn without an obvious cause.
Clinical signs in the newborn
- Petechiae
- Unexplained bruising
- Bleeding shortly after birth
These findings require immediate communication with neonatology and the transfusion service.
What the laboratory must do — STAT
Maternal and cord blood testing
Send the following samples urgently:
- EDTA blood – CBC plus Peripheral Blood Smear
- Evaluate platelet count and morphology
- Add smear comments if present: petechiae, bleeding signs
Anti-Platelet Antibody Testing
Collect and freeze samples for specialized testing:
- Maternal serum (plain tube)
- Test for anti-HPA antibodies
- especially anti-HPA-1a
Many reference laboratories require frozen serum aliquots, so early preparation saves critical time.
Key diagnostic tests
1. Maternal Anti-Platelet Antibody Screen
Detects antibodies such as:
- Anti-HPA-1a
- Other anti-HPA antibodies
Sent urgently to a reference immunohematology laboratory.
Clinical care should not wait for these results.
2. HPA Genotyping
Performed for:
- Mother
- Father
This test identifies platelet antigen incompatibility between parents and helps guide the selection of compatible platelet donors for the neonate.
Platelet transfusion strategy
If the neonate requires transfusion: HPA-compatible platelets are preferred.
Alternative option:
Maternal platelets
These must be prepared according to transfusion protocols:
- Washed
- Treated as required
- Irradiated if indicated
Proper documentation and preparation by the transfusion service is essential.
Practical bench tips that save time
- Freeze maternal serum early
Many reference labs require frozen samples with minimal handling.
- Document obstetric history clearly
Include details of previous pregnancies and neonatal outcomes on the request form.
- Maintain a list of HPA-compatible platelet donors
Or the nearest reference transfusion service that can provide compatible units quickly.
In suspected NAIT, minutes matter.
Why This Matters? In suspected NAIT, the laboratory plays a central role in early detection, diagnosis, and management planning.”
Other posts featuring Tareq Abadl on Hemostasis Today.
-
Nov 9, 2026, 10:08Ibrahim Mansoor: Rare Tests, Common Diseases – Rethinking Autoimmune Diagnostics
-
Nov 9, 2026, 09:29Veronica Sanchez: A Framework for Woman’s Health
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils